Angelica Peebles
Pharma Reporter at CNBC
Pharma reporter at CNBC | Past: Biotech at Bloomberg | Formerly LaVito | Opinions my own
Articles
-
1 week ago |
cnbc.com | Angelica Peebles
Residents of one of the states listed in the ‘Your Rights’ section of NBCUniversal’s Privacy Policy we have received your Global Privacy Control signal or you have opted out from the toggle below, but there is another step. To opt out of us selling or sharing/processing data such as your name, email address and other associated personal information for targeted advertising activities as described above, please submit the form below.
Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pill
3 weeks ago |
cnbc.com | Angelica Peebles
Eli Lilly CEO David Ricks on Q1 results, weight loss drug competition and status of weight-loss pillEli Lilly chairman and CEO David Ricks joins 'Squawk Box' to discuss the company's quarterly earnings results, weight loss drug demand and competition, status of the company's weight loss drug pill, potential impact of tariffs, drug production outlook, and more.
-
3 weeks ago |
flipboard.com | Angelica Peebles
NowThe golf star is teaming up with the investment firm TPG on a new sports-related fund. Fresh off finally securing a career grand slam with a thrilling win at the Masters, Rory McIlroy, the world’s second-ranked golfer, is rounding out another corner of his life: investing. Mr. McIlroy’s investment …
-
3 weeks ago |
cnbc.com | Angelica Peebles
CNBC's Angelia Peeble joins 'Squawk Box' to report on the company's quarterly earnings results.
-
1 month ago |
cnbc.com | Angelica Peebles
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment Mounjaro, the company's latest attempt to crack down on the booming industry of copycat drugs.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 6K
- Tweets
- 8K
- DMs Open
- Yes
About a month ago, the CEO of Mochi Health told me she wasn't worried about Eli Lilly suing her company for selling compounded tirzepatide. Today, Lilly is suing Mochi and three other telehealth sites https://t.co/ol8bKv3L7r
RT @mmcassella: Karoline Leavitt confirms the universal 10% baseline tariff will remain in effect during the 90-day pause, while country-sp…
RT @adamcancryn: NEW: Everyone knew RFK Jr. wanted to upend the health care system. They didn’t think he’d go this far, this fast. Now HH…
